Kathleen M. Curran

Vascular-targeted photodynamic therapy with BF2-chelated Tetraaryl-Azadipyrromethene agents: a multi-modality molecular imaging approach to therapeutic assessment

Annette T. Byrne, Aisling O’Connor, Michael J. Hall et al. · British Journal of Cancer · 2009 · 100 citations · Full text

FDG-PET as a "metabolic biopsy" tool in thoracic lesions with indeterminate biopsy

Sharon F. Hain, Kathleen M. Curran, Andrew D. Beggs et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2001 · 72 citations

Positron Emission Tomography, Medical Imaging, Pet-mri +10

Long-Term Precision of ¹⁸F-Fluoride PET Skeletal Kinetic Studies in the Assessment of Bone Metabolism

Michelle L. Frost, Glen M. Blake, So‐Jin Park‐Holohan et al. · Journal of Nuclear Medicine · 2008 · 66 citations · Full text

Gastrointestinal Side Effects Associated With Novel Therapies in Patients With Multiple Myeloma: Consensus Statement of the IMF Nurse Leadership Board

Lisa C. Smith, P Bertolotti, Kathleen M. Curran et al. · Clinical journal of oncology nursing · 2008 · 37 citations · Full text

International Myeloma Foundation, Hematological Malignancy, Oncology +11

Interpretability of a deep learning model in the application of cardiac MRI segmentation with an ACDC challenge dataset

Adrianna Janik, Jonathan D. Dodd, Georgiana Ifrim et al. · 2021 · 34 citations · Full text